Dolby Laboratories $DLB Shares Sold by Quilter Plc

Quilter Plc cut its stake in shares of Dolby Laboratories (NYSE:DLB) by 9.4% in the 2nd quarter, Holdings Channel reports. The fund owned 8,530 shares of the electronics maker’s stock after selling 880 shares during the quarter. Quilter Plc’s holdings in Dolby Laboratories were worth $633,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds also recently added to or reduced their stakes in the company. Cheviot Value Management LLC acquired a new position in shares of Dolby Laboratories in the first quarter valued at approximately $27,000. MAI Capital Management grew its position in Dolby Laboratories by 87.1% in the 1st quarter. MAI Capital Management now owns 348 shares of the electronics maker’s stock valued at $28,000 after buying an additional 162 shares during the last quarter. Caitong International Asset Management Co. Ltd acquired a new position in Dolby Laboratories in the 1st quarter valued at $29,000. Allworth Financial LP raised its position in Dolby Laboratories by 590.4% during the 2nd quarter. Allworth Financial LP now owns 504 shares of the electronics maker’s stock worth $37,000 after buying an additional 431 shares during the last quarter. Finally, Ameritas Advisory Services LLC acquired a new stake in shares of Dolby Laboratories in the 2nd quarter worth $48,000. 58.56% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In related news, SVP Shriram Revankar sold 7,000 shares of Dolby Laboratories stock in a transaction that occurred on Friday, August 22nd. The stock was sold at an average price of $74.92, for a total transaction of $524,440.00. Following the completion of the transaction, the senior vice president directly owned 70,435 shares in the company, valued at $5,276,990.20. The trade was a 9.04% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Kevin J. Yeaman sold 25,000 shares of the stock in a transaction on Tuesday, October 14th. The shares were sold at an average price of $68.87, for a total value of $1,721,750.00. Following the sale, the chief executive officer owned 114,725 shares in the company, valued at approximately $7,901,110.75. This trade represents a 17.89% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 57,000 shares of company stock worth $4,037,690 in the last ninety days. Insiders own 38.39% of the company’s stock.

Analysts Set New Price Targets

DLB has been the subject of a number of recent analyst reports. Robert W. Baird initiated coverage on shares of Dolby Laboratories in a research report on Friday, September 5th. They issued a “neutral” rating and a $74.00 price objective for the company. Tigress Financial lifted their price target on Dolby Laboratories from $112.00 to $114.00 and gave the company a “buy” rating in a research note on Friday, August 15th. Weiss Ratings reiterated a “hold (c-)” rating on shares of Dolby Laboratories in a research report on Thursday, November 13th. Baird R W raised Dolby Laboratories to a “hold” rating in a report on Friday, September 5th. Finally, Rosenblatt Securities decreased their target price on shares of Dolby Laboratories from $95.00 to $85.00 and set a “buy” rating on the stock in a research report on Wednesday. Three equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat.com, Dolby Laboratories has an average rating of “Moderate Buy” and a consensus price target of $92.00.

Dolby Laboratories Price Performance

NYSE DLB opened at $64.98 on Thursday. The business has a 50 day moving average price of $68.81 and a 200 day moving average price of $72.46. The company has a market capitalization of $6.23 billion, a P/E ratio of 23.80 and a beta of 0.97. Dolby Laboratories has a 1-year low of $64.02 and a 1-year high of $89.66.

Dolby Laboratories (NYSE:DLB) last posted its earnings results on Tuesday, November 18th. The electronics maker reported $0.99 EPS for the quarter, topping analysts’ consensus estimates of $0.70 by $0.29. Dolby Laboratories had a return on equity of 11.52% and a net margin of 19.62%.The company had revenue of $307.02 million for the quarter, compared to the consensus estimate of $305.76 million. During the same period in the previous year, the business earned $0.61 earnings per share. Dolby Laboratories’s quarterly revenue was up .7% compared to the same quarter last year. Dolby Laboratories has set its FY 2026 guidance at 4.190-4.340 EPS. Q1 2026 guidance at 0.790-0.940 EPS. On average, research analysts expect that Dolby Laboratories will post 2.94 earnings per share for the current fiscal year.

Dolby Laboratories Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, December 10th. Shareholders of record on Tuesday, December 2nd will be given a dividend of $0.36 per share. The ex-dividend date is Tuesday, December 2nd. This is an increase from Dolby Laboratories’s previous quarterly dividend of $0.33. This represents a $1.44 dividend on an annualized basis and a yield of 2.2%. Dolby Laboratories’s dividend payout ratio (DPR) is presently 48.35%.

Dolby Laboratories Profile

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.